Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
2002 1
2003 1
2005 2
2006 3
2007 2
2008 2
2009 3
2010 3
2011 1
2012 1
2013 1
2015 1
2022 2
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

20 results
Results by year
Filters applied: . Clear all
Page 1
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Boutry C, Hastie A, Diez-Domingo J, Tinoco JC, Yu CJ, Andrews C, Beytout J, Caso C, Cheng HS, Cheong HJ, Choo EJ, Curiac D, Di Paolo E, Dionne M, Eckermann T, Esen M, Ferguson M, Ghesquiere W, Hwang SJ, Avelino-Silva TJ, Kosina P, Liu CS, Markkula J, Moeckesch B, Murta de Oliveira C, Park DW, Pauksens K, Pirrotta P, Plassmann G, Pretswell C, Rombo L, Salaun B, Sanmartin Berglund J, Schenkenberger I, Schwarz T, Shi M, Ukkonen B, Zahaf T, Zerbini C, Schuind A, Cunningham AL; Zoster-049 Study Group. Boutry C, et al. Clin Infect Dis. 2022 Apr 28;74(8):1459-1467. doi: 10.1093/cid/ciab629. Clin Infect Dis. 2022. PMID: 34283213 Free PMC article. Clinical Trial.
Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination.
Strezova A, Diez-Domingo J, Al Shawafi K, Tinoco JC, Shi M, Pirrotta P, Mwakingwe-Omari A; Zoster-049 Study Group. Strezova A, et al. Open Forum Infect Dis. 2022 Oct 23;9(10):ofac485. doi: 10.1093/ofid/ofac485. eCollection 2022 Oct. Open Forum Infect Dis. 2022. PMID: 36299530 Free PMC article.
Plasma protein therapies: current and future perspectives.
Farrugia A, Robert P. Farrugia A, et al. Among authors: robert p. Best Pract Res Clin Haematol. 2006;19(1):243-58. doi: 10.1016/j.beha.2005.01.002. Best Pract Res Clin Haematol. 2006. PMID: 16377552 Review.
Cost of hospital-acquired infection.
Hassan M, Tuckman HP, Patrick RH, Kountz DS, Kohn JL. Hassan M, et al. Among authors: patrick rh. Hosp Top. 2010 Jul-Sep;88(3):82-9. doi: 10.1080/00185868.2010.507124. Hosp Top. 2010. PMID: 20805070
Neurofilaments bind tubulin and modulate its polymerization.
Bocquet A, Berges R, Frank R, Robert P, Peterson AC, Eyer J. Bocquet A, et al. Among authors: robert p. J Neurosci. 2009 Sep 2;29(35):11043-54. doi: 10.1523/JNEUROSCI.1924-09.2009. J Neurosci. 2009. PMID: 19726663 Free PMC article.
Complex regional pain syndrome after infliximab infusion.
Chahine LM, Patrick R, Tavee J. Chahine LM, et al. Among authors: patrick r. J Pain Symptom Manage. 2008 Sep;36(3):e2-4. doi: 10.1016/j.jpainsymman.2008.03.006. Epub 2008 Jul 18. J Pain Symptom Manage. 2008. PMID: 18639436 Free article. No abstract available.
20 results